Study identifies increase in antibiotic-resistant typhoid

Ciprofloxacin is the first-line drug for treating typhoid fever in many countries in Africa with a high disease burden, but the emergence of non-susceptibility

Related Keywords

Malawi ,United Kingdom ,Typhis Typhi ,Philip Ashton ,Care Research United Kingdom ,National Institute For Health ,Melinda Gates Foundation ,Liverpool Wellcome Programme ,Wellcome ,Malawi Liverpool Wellcome Programme ,Queen Elizabeth Central Hospital ,Between October ,National Institute ,Care Research ,Newswise ,Yphoid Antibiotic Resistant Salmonella ,All Journal News ,Public Health ,University Of Liverpool ,